Articles

10.4244/EIJV7I3A54 Jul 29, 2011
Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial
Hermiller J, Nikolsky E, Lansky AJ, Applegate R, Sanz M, Yaqub M, Sood P, Cao S, Sudhir K, Stone GW
free

10.4244/EIJV7I3A55 Jul 29, 2011
Two-year clinical outcomes of paclitaxel-eluting stents for in-stent restenosis in patients from the ARRIVE programme
Lee M, Yang T, Lasala J, Cox D, Bowman T, Starzyk R, Dawkins K
free

10.4244/EIJV7I3A56 Jul 29, 2011
Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial
Jensen L, Maeng M, Thayssen P, Villadsen AB, Krusell L, Bøtker H, Pedersen K, Aaroe J, Christiansen E, Vesterlund T, Hansen K, Ravkilde J, Tilsted H, Lassen JF, Thuesen L
free

10.4244/EIJV7I3A57 Jul 29, 2011
Cost analysis of four major drug-eluting stents in diabetic populations
Saadi R, Cohen S, Banko D, Thompson M, Duong M, Ferko N
free

10.4244/EIJV7I3A59 Jul 29, 2011
Tissue characterisation of atherosclerotic plaque in the left main: an in vivo intravascular ultrasound radiofrequency data analysis
Mercado N, Moe T, Pieper M, House J, Dolla W, Seifert L, Stolker J, Lindsey J, Kennedy KK, Marso S
free

10.4244/EIJV7I3A61 Jul 29, 2011
Paclitaxel-iopromide coated balloon followed by “bail-out” bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation
Milewski K, Tellez A, Aboodi M, Conditt G, Yi G, Thim T, Stenoien M, McGregor J, Gray WA, Virmani R, Granada JF, Kaluza G
free

10.4244/EIJV7I3A62 Jul 29, 2011
Virtual bench testing of new generation coronary stents
Mortier P, De Beule M, Segers P, Verdonck P, Verhegghe B
free

10.4244/EIJV7I3A63 Jul 29, 2011
Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence
Butera G, Biondi-Zoccai G, Sangiorgi G, Abella R, Giamberti A, Bussadori C, Sheiban I, Saliba Z, Santoro T, Pelissero G, Carminati M, Frigiola A
free

10.4244/EIJV7I3A64 Jul 29, 2011
Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application
Farooq V, Onuma Y, Radu M, Okamura T, Gomez-Lara J, Brugaletta S, Gogas B, van Geuns R, Regar E, Schultz C, Windecker S, Lefèvre T, Brueren B, Powers J, Perkins L, Rapoza R, Virmani R, Garcia-Garcia H, Serruys PW
free

10.4244/EIJV7I3A65 Jul 29, 2011
How should I treatsevere calcific coronary artery disease?
Fernandez J, Hobson A, McKenzie D, Talwar S, O'Kane P
free

10.4244/EIJV7I3A66 Jul 29, 2011
Tools & Techniques: PFO/ASD closure
Pavlovic M, Buellesfeld L, Meier B
free

10.4244/EIJV7I2A29 Jun 30, 2011
EuroPCR 2011: the ongoing challenge of initiatives and innovations
Serruys PW
free

10.4244/EIJV7I2A30 Jun 30, 2011
Peripheral interventions: how long will they remain a missed opportunity?
Di Mario C, Roffi M
free
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved